A3 bromoacetamide (BrAc) type N-glycan is a glycan reagent that has a reducing end bromoacetamide group and can be used to glycosylate peptides or proteins via cysteine-free thiol groups.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
